Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Osteoporosis Reports
Metadata
Title
Therapeutic potential of parathyroid hormone
Authors
Felicia Cosman, MD
Robert Lindsay, MBChC, PhD
Publication date
01-03-2004
Publisher
Current Medicine Group
Published in
Current Osteoporosis Reports / Issue 1/2004
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-004-0008-0

Other articles of this Issue 1/2004

Current Osteoporosis Reports 1/2004 Go to the issue

News

Web alert

OriginalPaper

Rational use of oral bisphosphonates for the treatment of osteoporosis

OriginalPaper

Intravenous bisphosphonate therapy for osteoporosis: Where do we stand?

OriginalPaper

Is it ethical to use placebos in osteoporosis clinical trials?

OriginalPaper

Hormone replacement therapy: Review, update, and remaining questions after the women’s health initiative study